FX.co ★ Myriad Genetics Partners With Hannah Storm To Promote Breast Cancer Risk Assessment Program

Myriad Genetics Inc. (MYGN) has entered into a partnership with Hannah Storm, a widely recognized sports broadcaster, who has recently shared her personal experience with breast cancer.

Under this agreement, Storm will serve as an ambassador for Myriad Genetics' Breast Cancer Risk Assessment Program, which includes the MyRisk with RiskScore Hereditary Cancer Test. This initiative encompasses both hereditary cancer testing and polygenic risk assessment across all ancestral backgrounds. Storm's role will involve advocating for the crucial collection of comprehensive family health histories related to cancer and promoting a deeper understanding of the associated cancer risks.